Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial
Ebrahim Salehifar et al.
CLINICAL DRUG INVESTIGATION (2020)
Differences in cancer survival by remoteness of residence: an analysis of data from a population-based cancer registry
Nina Afshar et al.
CANCER CAUSES & CONTROL (2020)
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
Charles L. Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Efficacy of gabapentin for the prevention of paclitaxel induced peripheral neuropathy: A randomized placebo controlled clinical trial
Mahdi Aghili et al.
BREAST JOURNAL (2019)
Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double-blind, placebo-controlled phase III study in Asian patients
Masayuki Baba et al.
JOURNAL OF DIABETES INVESTIGATION (2019)
Somatosensory predictors of response to pregabalin in painful chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled, crossover study
Alexander Hincker et al.
PAIN (2019)
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis
Sara Pusceddu et al.
CANCERS (2019)
Effectiveness of gabapentin pharmacotherapy in chemotherapy-induced peripheral neuropathy
Magdalena Magnowska et al.
GINEKOLOGIA POLSKA (2018)
Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis
Jihoon Kang et al.
INVESTIGATIONAL NEW DRUGS (2018)
Binding Characteristics and Analgesic Effects of Mirogabalin, a Novel Ligand for the α2δ Subunit of Voltage-Gated Calcium Channels
Yuki Domon et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane-induced sensory neuropathy: A randomized clinical trial
Razieh Avan et al.
JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2018)
Dietary Intake of Magnesium or Calcium and Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Patients
Evertine Wesselink et al.
NUTRIENTS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Efficacy of Nab-Paclitaxel Plus Gemcitabine and Prognostic Value of Peripheral Neuropathy in Patients with Metastatic Pancreatic Cancer
Min Su You et al.
GUT AND LIVER (2018)
A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis
Daniel H. Ahn et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2017)
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial
Andrew H. Ko et al.
ONCOLOGIST (2017)
Pregabalin for the Prevention of Oxaliplatin-Induced Painful Neuropathy: A Randomized, Double-Blind Trial
Daniel Ciampi De Andrade et al.
ONCOLOGIST (2017)
Efficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer in a Korean population: A single-center cohort study
In Rae Cho et al.
SEMINARS IN ONCOLOGY (2017)
Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study
Ruihua Xu et al.
BMC CANCER (2017)
Efficacy and safety of duloxetine in Chinese breast cancer patients with paclitaxel-induced peripheral neuropathy
Jiani Wang et al.
CHINESE JOURNAL OF CANCER RESEARCH (2017)
Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples
Alessandro Ottaiano et al.
ANTICANCER RESEARCH (2017)
A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review
Evan L. Fogel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Can pregabalin prevent paclitaxel-associated neuropathy?-An ACCRU pilot trial
Shivani S. Shinde et al.
SUPPORTIVE CARE IN CANCER (2016)
FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience
Muralidharan K. Chllamma et al.
BRITISH JOURNAL OF CANCER (2016)
Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer
Hideki Ueno et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse
A. Orlandi et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
Improvement in advanced pancreatic cancer survival with novel chemotherapeutic strategies - experience of a community based hospital
A. Hann et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2016)
FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer: A Single Centre Cohort Study
S. J. Rombouts et al.
JOURNAL OF CANCER (2016)
Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma
Eric A. Mellon et al.
ACTA ONCOLOGICA (2015)
FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma
Eran Sadot et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Metastatic Pancreatic Carcinoma and Experience with FOLFIRINOX - a Cross Sectional Analysis From a Developing Country
Muhammad Nauman Zahir et al.
Asian Pacific Journal of Cancer Prevention (2015)
Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial
Yasuo Hirayama et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2015)
Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study
Eiji Oki et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2015)
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)
Deirdre R. Pachman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
FOLFIRINOX for Locally Advanced Pancreatic Adenocarcinoma: Results of an AGEO Multicenter Prospective Observational Cohort
L. Marthey et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Comparison of the Effects of Single Doses of Elcatonin and Pregabalin on Oxaliplatin-Induced Cold and Mechanical Allodynia in Rats
Manahito Aoki et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2014)
FOLFIRINOX for Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: The Royal Marsden Experience
Sing Yu Moorcraft et al.
CLINICAL COLORECTAL CANCER (2014)
Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: A single institution retrospective review
Florian Hohla et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)
Charles L. Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy
Toru Kono et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer
Dong-sheng Zhang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy A Randomized Clinical Trial
Ellen M. Lavoie Smith et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer
Brian A. Boone et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity
Krishna S. Gunturu et al.
MEDICAL ONCOLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
FOLFIRINOX in Locally Advanced Pancreatic Cancer: The Massachusetts General Hospital Cancer Center Experience
Jason E. Faris et al.
ONCOLOGIST (2013)
Modified FOLFIRINOX Regimen With Improved Safety and Maintained Efficacy in Pancreatic Adenocarcinoma
Hemchandra Mahaseth et al.
PANCREAS (2013)
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
Peter J. Hosein et al.
BMC CANCER (2012)
Further Data Supporting That Paclitaxel-Associated Acute Pain Syndrome Is Associated With Development of Peripheral Neuropathy
Brandi N. Reeves et al.
CANCER (2012)
Treatment options for advanced pancreatic cancer: a review
Rahma Warsame et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Objective evaluation of the alleviating effects of Goshajinkigan on peripheral neuropathy induced by paclitaxel/carboplatin therapy: A multicenter collaborative study
Hiroi Kaku et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen
Masanori Nishioka et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2011)
Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1
Charles L. Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma
Elias Assaf et al.
ONCOLOGY (2011)
Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states
Amin Boroujerdi et al.
PAIN (2011)
Effect of calcium and magnesium on neurotoxicity and blood platinum concentrations in patients receiving mFOLFOX6 therapy: a prospective randomized study
Keiichiro Ishibashi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2010)
Advanced pancreatic carcinoma: current treatment and future challenges
Anastasios Stathis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Mechanical Allodynia Induced by Paclitaxel, Oxaliplatin and Vincristine: Different Effectiveness of Gabapentin and Different Expression of Voltage-Dependent Calcium Channel α2δ-1 Subunit
Punarn Gauchan et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy - A phase 3 randomized, double-blind, placebo-controlled, crossover trial (NOOC3)
Ravi D. Rao et al.
CANCER (2007)
Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit
W. Xiao et al.
NEUROSCIENCE (2007)
Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer -: A Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer Study
T Conroy et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Ducky mouse phenotype of epilepsy and ataxia is associated with mutations in the Cacna2d2 gene and decreased calcium channel current in cerebellar Purkinje cells
J Barclay et al.
JOURNAL OF NEUROSCIENCE (2001)
Share Paper
